As the next round of Medicare drug pricing negotiations get underway, experts predict President Trump may seek to weaken the program.

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

Relay Therapeutics Inc. (NASDAQ:RLAY) is a leading clinical-stage precision medicines firm focused on cancer treatments. The ...

During a fireside chat at the annual J.P. Morgan Healthcare Conference on January 13th, Mayo Clinic chief administrative ...

An executive order designating cartels as terrorist organizations will expand prosecutors' jurisdictions, affect relations ...

These stocks have climbed more than 80% and 200% over the past three years. But demand for their products and potential ...

Aardvark Therapeutics files for IPO. Company develops hunger-targeting obesity drug ARD-101 and ARD-201, led by CEO Tien Lee.

Former New York Giants safety Jabrill Peppers has pleaded guilty to a drug charge dating back to an October domestic violence case.

President Trump's executive order reverses Biden's order on prescription drugs, potentially increasing costs for Medicare and Medicaid enrollees.

The executive order, which Biden signed in October 2022, had not spurred any lower drug prices by the time Trump revoked it Jan. 20. The order directed the Health and Human Services Department ...

For a doctor or advanced practice registered nurse to be able to write those certifications in Kentucky, they must meet five ...

The lawsuit, filed by a victim's father, said his son was given alcohol to the point of unconsciousness and asserts that the designated driver consumed drugs.